Search results
Results from the WOW.Com Content Network
Hyperinsulinemic hypoglycemia describes the condition and effects of low blood glucose caused by excessive insulin. Hypoglycemia due to excess insulin is the most common type of serious hypoglycemia. It can be due to endogenous or injected insulin.
Nesidioblastosis is a controversial medical term for hyperinsulinemic hypoglycemia attributed to excessive insulin production by pancreatic beta cells that have an abnormal microscopic appearance. The term was coined in the first half of the 20th century.
Recurrent mild hypoglycemia may fit a reactive hypoglycemia pattern, but this is also the peak age for idiopathic postprandial syndrome, and recurrent "spells" in this age group can be traced to orthostatic hypotension or hyperventilation as often as demonstrable hypoglycemia. [citation needed] Insulin-induced hypoglycemia
In adults, severe hyperinsulinemic hypoglycemia is often due to an insulinoma, an insulin-secreting tumor of the pancreas. [citation needed] Insulin levels above 3 μU/mL are inappropriate when the glucose level is below 50 mg/dL (2.8 mM), and may indicate hyperinsulinism as the cause of the hypoglycemia.
[3] [2] Post-gastric bypass hypoglycemia can be prevented by eating smaller, more frequent meals, avoiding sugar-filled foods, as well as medical treatment with an alpha-glucosidase inhibitor, diazoxide, or octreotide. [3] [2] Some causes of hypoglycemia require treatment of the underlying cause to best prevent hypoglycemia. [2]
Congenital hyperinsulinism (HI) has been referred to by a variety of names; nesidioblastosis and islet cell adenomatosis were favored in the 1970s, beta cell dysregulation syndrome or dysmaturation syndrome in the 1980s, and persistent hyperinsulinemic hypoglycemia of infancy (PHHI) in the 1990s.
This helps stimulate gastric emptying, allowing food to more easily pass through your digestive system. While bloating can feel uncomfortable, rest assured that occasional bloating is totally normal.
Mutations in the monocarboxylate transporter 1 (MCT1) gene have been associated with three diseases: hyperinsulinemic hypoglycemia, familial 7 (HHF7); monocarboxylate transporter 1 deficiency (MCTD1); and erythrocyte lactate transporter defect (formerly, myopathy due to lactate transport defect). [9] (See also bioenergetic systems.)